NO During CPB in Neonates to Reduce Risk of AKI

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: AKI, CHD - Congenital Heart Disease, Surgery

In brief

Acute kidney injury (AKI) following cardiac surgery for congenital heart defects (CHD) in children affects up to 60% of high risk-patients and is a major cause of both short- and long-term morbidity and mortality. Despite effort, to date, no successful therapeutic agent has gained widespread success in preventing this postoperative decline in renal function. Nitric oxide is an intricate regulator of acute inflammation and coagulation and is a potent vasodilator. The investigators hypothesize that nitric oxide, administered during cardiopulmonary bypass (CPB), may reduce the incidence of AKI.

Key facts

Study ID
NCT04216927
Run by
Children's Hospital Medical Center, Cincinnati
People needed
40
Starts
2023-01-10
Expected to finish
2027-06-30
Last updated by the study team
2026-08-05

Who can join

Age: 0 and older, up to 0. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.